The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Amosova N.A.

FGBU "Gosudarstvennyĭ nauchnyĭ tsentr Rossiĭskoĭ Federatsii - Federal'nyĭ meditsinskiĭ biofizicheskiĭ tsentr im. A.I. Burnaziana" FMBA, Moskva

Smolentseva I.G.

Kafedra nevrologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia;
Tsentr ékstrapiramidnykh zabolevaniĭ, Moskva

Маslyuk О.А.

«Central state medical Academy» of Department for presidential Affairs of RF, Moscow, Russia

Pavlov Iu.V.

Fakul'tetskaia khirurgicheskaia klinika im. N.N. Burdenko Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Gavrilov E.L.

«Central state medical Academy» of Department for presidential Affairs of RF, Moscow, Russia

An analysis of causes of death in patients with Parkinson’s disease

Authors:

Amosova N.A., Smolentseva I.G., Маslyuk О.А., Pavlov Iu.V., Gavrilov E.L.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(6‑2): 70‑72

DOI: 10.17116/jnevro20171176270-72

Read: 45750 times

Download PDF (RU)
Contact the author
Table of contents

AN ANALYSIS OF CAUSES OF DEATH IN PATIENTS WITH PARKINSON’S DISEASE
AN ANALYSIS OF CAUSES OF DEATH IN PATIENTS WITH PARKINSON’S DISEASE

To cite this article:

Amosova NA, Smolentseva IG, Маslyuk ОА, Pavlov IuV, Gavrilov EL. An analysis of causes of death in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(6‑2):70‑72. (In Russ.)
https://doi.org/10.17116/jnevro20171176270-72

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Neurochemical mechanisms of tremor in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):64-72
Clinical presentation and diagnosis of Parkinson’s disease in patients with schi­zophrenia spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):73-80
Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90
Bladder dysfunction in patients with stages I—III of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):91-99
Chro­nic epidural spinal cord stimulation for gait impairments in Parkinson’s disease and atypical parkinsonism. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):100-112
Long-term outcomes in patients after hospital treatment for COVID-19 (three-year follow-up data). Russian Journal of Preventive Medi­cine. 2024;(12):114-121
A portrait of a doctor with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):160-164
Features of drug therapy in patients with chro­nic heart failure in real clinical practice (chronic heart failure regi­stry in the Tyumen region). Russian Cardiology Bulletin. 2024;(4):72-79
Pathomorphosis of the Parkinson’s disease against the background of DBS STN. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):21-27
The effect of bila­teral subthalamic nucleus deep brain stimulation on gait and bala­nce in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):94-101
Abstract:

Objective. To determine population mortality rate and reasons of death in Parkinson’s disease (PD). Material and methods. To analyze reasons of death, medical death certificates and postmortem records as well as official results of the Federal state statistics service were used. According to the register of Parkinson’s disease (PD) patients during 2009—2012, the total mortality was 9.9%. The average age of patients died from the disease was 74.3 ± 2.4 years. The main reasons of death were PD (36.2%), circulatory illnesses (27.6%), respiratory diseases (12.1%), malignant neoplastic diseases (12.1%), other reasons (12.0%). Direct reasons of death in patients with PD were the complications of underlying disease in connection with the development of immobility and comorbidities. Timely correction of complications and comorbidities is a main strategy to extend life expectancy in patients with PD.

Keywords:

Parkinson’s disease
reasons of death
registry

Authors:

Amosova N.A.

FGBU "Gosudarstvennyĭ nauchnyĭ tsentr Rossiĭskoĭ Federatsii - Federal'nyĭ meditsinskiĭ biofizicheskiĭ tsentr im. A.I. Burnaziana" FMBA, Moskva

Smolentseva I.G.

Kafedra nevrologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia;
Tsentr ékstrapiramidnykh zabolevaniĭ, Moskva

Маslyuk О.А.

«Central state medical Academy» of Department for presidential Affairs of RF, Moscow, Russia

Pavlov Iu.V.

Fakul'tetskaia khirurgicheskaia klinika im. N.N. Burdenko Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Gavrilov E.L.

«Central state medical Academy» of Department for presidential Affairs of RF, Moscow, Russia

Close metadata

References:

  1. Hoehn M, Yahr M. Parkinsonism: onset, progression, and mortality. Neurology. 1967;17(5):427-427. https://doi.org/10.1212/WNL.17.5.427
  2. Shaw KM, Lees AJ, Stern GM. The impact of treatment with levodopa on Parkinson’s disease. Quarterly Journal of Medicine. 1980;49(3):283-293. https://doi.org/10.1093/oxfordjournals.qjmed.a067623
  3. Clarke CE. Mortality from Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2000;68(2):254-255. https://doi.org/10.1136/jnnp.68.2.254
  4. Curtis L, Lees A, Stern G, Marmot M. Effect of L-Dopa on course of Parkinson’s disease. The Lancet. 1984;324(8396):211-212. https://doi.org/10.1016/S0140-6736(84)90493-8
  5. Marttila R, Rinne U, Siirtola T, Sonninen V. Mortality of patients with parkinson’s disease treated with levodopa. Journal of Neurology. 1977;216(3):147-153. https://doi.org/10.1007/BF00313615
  6. Levin OS. Fenomenologia i lechenie decompensazii bolezni Parkinsona. Nevrologicheskiy Jurnal. 2007;1:8-15. (In Russ.).
  7. Shtok VN. Ekstrapiramidnye rasstroistva. Rukovodstvo po diagnostike i lecheniyu. In: V.N. Shtok, I.A. Ivanova-Smolenskaya, O.S. Levin, eds. M.: MEDpress-inform; 2002. (In Russ.).
  8. Fahn S. Parkinson’s disease: 10 years of progress, 1997—2007. Mov Disord. 2010;25(1):2-14. https://doi.org/10.1002/mds.22796
  9. Guttman M, Slaughter P, Theriault M, DeBoer D, Naylor C. Parkinsonism in Ontario: Increased mortality compared with controls in a large cohort study. Neurology. 2001;57(12):2278-2282. https://doi.org/10.1212/WNL.57.12.2278
  10. Hely M, Morris J, Reid W, Trafficante R. Sydney multicenter study of Parkinson’s disease: Non-L-dopa-responsive problems dominate at 15 years. Movement Disorders. 2005;20(2):190-199. https://doi.org/10.1002/mds.20324
  11. Herlofson K, Lie S, Arsland D, Larsen J. Mortality and Parkinson disease: A community based study. Neurology. 2004;62(6):937-942. https://doi.org/10.1212/01.wnl.0000115116.56955.50
  12. Muller J, Wenning G, Jellinger K, McKee A, Poewe W, Litvan I. Progression of Hoehn and Yahr stages in parkinsonian disorders: A clinicopathologic study. Neurology. 2000;55(6):888-891. https://doi.org/10.1212/WNL.55.6.888
  13. Morgan J, Currie L, Harrison M, Bennett J, Trugman J, Wooten G. Mortality in Levodopa-Treated Parkinson’s Disease. Parkinson’s Disease. 2014:1-8. https://doi.org/2014/426976
  14. Louis E, Marder K, Cote L, Tang M, Mayeux R. Mortality From Parkinson Disease. Archives of Neurology. 1997;54(3):260-264. https://doi.org/10.1001/archneur.1997.00550150024011
  15. Marder K, Leung D, Tang M, Bell K, Dooneief G, Cote L, Stern Y, Mayeux R. Are demented patients with Parkinson’s disease accurately reflected in prevalence surveys? A survival analysis. Neurology. 1991;41(8): 1240-1240. https://doi.org/10.1212/WNL.41.8.1240
  16. Levy G, Tang MX, Louis ED et al. The association of incident dementia with mortality in PD. Neurology. 2002;59(11):1708-1713. https://doi.org/10.1212/01.WNL.0000036610.36834.E0
  17. De Lau L, Breteler M. Epidemiology of Parkinson’s disease. The Lancet Neurology. 2006;5(6):525-535. https://doi.org/10.1016/S1474-4422(06)70471-9
  18. D Lau L, Schipper C, Hofman A, Koudstaal P, Breteler M. Prognosis of Parkinson’s Disease. Arch Neurol. 2005;62(8):1265. https://doi.org/10.1001/archneur.62.8.1265
  19. Hughes T, Ross H, Mindham R, Spokes E. Mortality in Parkinson’s disease and its association with dementia and depression. Acta Neurologica Scandinavica. 2004;110(2):118-123. https://doi.org/10.1111/j.1600-0404.2004.00292.x
  20. Diem-Zangerl A, Seppi K, Wenning G, Trinka E, Ransmayr G, Oberaigner W, Poewe W. Mortality in Parkinson’s disease: A 20-year follow-up study. Movement Disorders. 2009;24(6):819-825. https://doi.org/10.1002/mds.22414
  21. Rajput AH, Uitti RJ, Rajput A, Offord KP. Mortality in Parkinson’s disease. Mov Disord. 2010;25:507-508. https://doi.org/10.1002/mds.22914
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.